Beeinflusst Endometriose die Prognose von Patientinnen mit klarzelligem Ovarial-Karzinom?

H S Kim
In: Geburtshilfe und Frauenheilkunde · 2016 · vol. 76(04) , pp. 312–313 · doi:10.1055/s-0042-101102 · W2761483261
OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-03 ⓘ

This study investigated the impact of endometriosis on the prognosis of patients with clear cell ovarian carcinoma, a subtype associated with the worst outcomes in advanced stages.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-09 · read from full text ⓘ

This article reviews a study by Kim et al. investigating whether the presence of endometriosis impacts the prognosis of patients diagnosed with ovarian clear cell carcinoma, which carries the worst outlook among advanced epithelial ovarian cancer subtypes. The authors reference a two-center cohort study that analyzed clinical data to determine if endometriosis serves as a prognostic factor for survival outcomes in this specific histological type. The summary highlights the clinical interest in understanding how comorbid endometriosis might alter disease progression or treatment response in these patients. This paper is centrally about endometriosis — specifically its potential influence on the prognosis of ovarian clear cell carcinoma.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Hintergrund: Ovarialkrebs ist die zweit-häufigste bösartige Erkrankung des weiblichen Genitaltrakts. Unter den verschiedenen histologischen Typen des Ovarialkarzinoms geht das Klarzellkarzinom ("Ovarian Clear Cell Carcinoma", OCCC) bei fortgeschrittener Erkrankung mit der schlechtesten Prognose einher. Kim et al. haben den Einfluss einer Endometriose-Erkrankung auf die Prognose des OCCC untersucht.
Full text 998 characters · extracted from oa-doi-fallback · click to expand
Subscribe to RSS Please copy the URL and add it into your RSS Feed Reader. https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000020.xml Geburtshilfe Frauenheilkd 2016; 76(04): 312-313 DOI: 10.1055/s-0042-101102 DOI: 10.1055/s-0042-101102 Aktuell referiert Onkologie Beeinflusst Endometriose die Prognose von Patientinnen mit klarzelligem Ovarial-Karzinom? Further Information Publication History Publication Date: 26 April 2016 (online) Hintergrund: Ovarialkrebs ist die zweit-häufigste bösartige Erkrankung des weiblichen Genitaltrakts. Unter den verschiedenen histologischen Typen des Ovarialkarzinoms geht das Klarzellkarzinom („Ovarian Clear Cell Carcinoma“, OCCC) bei fortgeschrittener Erkrankung mit der schlechtesten Prognose einher. Kim et al. haben den Einfluss einer Endometriose-Erkrankung auf die Prognose des OCCC untersucht. Kim HS et al. Effect of endometriosis on the prognosis of ovarian clear cell carcinoma: A two-center cohort study […]. Ann Surg Oncol 2015; 22: 2738–2745

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

die_deep_infiltrating

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK